News Sentiment

TELO sentiment intelligence

Telomir Pharmaceuticals, Inc. Common Stock news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 53 Balanced news tone 68 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 1.23 Week of 10 Jul 2026
Weighted tone 53/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

81/100 classification confidence.

Company focus 60

directly relevant articles

Source quality 5

high-authority source matches

Trend context Trend inactive

-3.1% over one week, -2.4% over four weeks, trend inactive, and below fair value.

Latest direct headline Positive

Why Did Vir Biotechnology Stock Surge 60% After-Hours Today?

Market Reaction

Balanced read

62/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 81/100 classification
One-week reaction -3.1% Price reacting lower
Trend fit Trend inactive -2.4% over four weeks
Fair value -63.6% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 17
Neutral 43
Negative 8

Relevance

Why the article matched

Direct first
Direct company coverage 60
Industry context 8
Sector context 0

Sources

Coverage mix

Publishers
TradingView 8
Market source 7
TradingKey 6
Stock Titan 6
ACCESS Newswire 4
dars.gov.et 3
Barron's 3
Stocktwits 2

Event Lens

What the news is about

Classified themes
Market update 40
Earnings 22
Balance sheet 2
Deals and strategy 2
Regulatory and legal 1
Guidance 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-60 of 68
www.marketscreener.com Direct company coverage

Telomir Pharmaceuticals, Inc. Announces CFO Changes, Effective June 6, 2026

Telomir Pharmaceuticals, Inc. announced a change in its Chief Financial Officer position, effective June 6, 2026. Alan Weichselbaum is no longer serving as CFO, and Andriy Mushak has been appointed as the Company's fractional Chief Financial Officer. Mr. Mushak is a Certified Pub

Tone
Neutral 50/100
Event
Market update
Published
08 Jun 2026 21:10
Source
www.marketscreener.com
Finviz Direct company coverage

TELO - Telomir Pharmaceuticals Inc Stock Price and Quote

This article provides comprehensive financial data and recent news for Telomir Pharmaceuticals Inc (TELO). It details the company's stock performance, key financial metrics, insider ownership, and institutional transactions. The latter part of the article highlights numerous anno

Tone
Positive 70/100
Event
Market update
Published
30 May 2026 18:12
Source
Finviz
ChartMill Direct company coverage

TELO Stock Price, Quote & Chart | TELOMIR PHARMACEUTICALS INC (NASDAQ:TELO)

This article provides a comprehensive overview of TELOMIR PHARMACEUTICALS INC (NASDAQ:TELO) stock, including its current price, performance metrics, and key statistics. It also details the company's technical and fundamental analysis ratings from ChartMill, future earnings dates,

Tone
Neutral 50/100
Event
Earnings
Published
27 May 2026 04:08
Source
ChartMill
Stock Titan Direct company coverage

Telomir (TELO) director swaps 25K options for new lower-priced grant

Telomir Pharmaceuticals director Edward Clouston MacPherson restructured his stock options by canceling an existing grant of 25,000 shares with a $5.02 exercise price and replacing it with a new 25,000-share option at a lower exercise price of $1.30. This transaction, revealed in

Tone
Neutral 50/100
Event
Market update
Published
23 May 2026 01:39
Source
Stock Titan
Stock Titan Direct company coverage

Telomir (NASDAQ: TELO) CEO reshapes 4M+ options at lower $1.30 strike

Telomir Pharmaceuticals, Inc. CEO and Chairman Erez Aminov recently modified his stock option awards. He canceled previously granted options totaling nearly 4 million shares at higher exercise prices ($2.10 and $5.02) and received new, fully exercisable options for the same numbe

Tone
Positive 63/100
Event
Market update
Published
23 May 2026 00:10
Source
Stock Titan